CDIPT — patent landscape

Top predicted compounds (top 20 by supporting neighbours, then confidence)

Compound	Confidence	Supporting neighbours
SCHEMBL4699731	1.00	2/20
SCHEMBL16111548	1.00	2/20
SCHEMBL29358745	1.00	2/20
SCHEMBL29380618	1.00	2/20
SCHEMBL29931136	1.00	2/20
SCHEMBL4697866	0.89	2/20
SCHEMBL24532075	0.89	2/20
SCHEMBL4697696	0.86	2/20
SCHEMBL23092285	0.86	2/20
SCHEMBL29688472	0.86	2/20
SCHEMBL22024695	0.86	2/20
SCHEMBL16136600	0.84	2/20
SCHEMBL24532058	0.83	2/20
SCHEMBL4699947	0.83	2/20
SCHEMBL22025026	0.82	2/20
SCHEMBL22119546	0.82	2/20
SCHEMBL24532062	0.82	2/20
SCHEMBL18804561	0.81	2/20
SCHEMBL22024561	0.81	2/20
SCHEMBL22025030	0.81	2/20

Clinical trials — most relevant to CDIPT by text similarity (a relevance ranking, not an exhaustive list)

Trial	Phase	Status
European Celecoxib Trial in Primary Breast Cancer	PHASE3	COMPLETED
Cytidine and Omega-3 Fatty Acids in Bipolar Disorder	PHASE2	COMPLETED
Lovaza's Effect on the Activation of Platelets	PHASE2	COMPLETED
Effect of Gemfibrozil on Serum Glycosylphosphatidylinositol (GPI) Phospholipase D and Triglycerides	PHASE1	COMPLETED
Phase I Clinical Trial of CDP1 in Patients With Advanced Solid Tumors	PHASE1	COMPLETED
Analysis of Tissues From Patients in Trial of Myo-Inositol to Prevent Lung Cancer	PHASE1	COMPLETED
CD40 Agonist, Flt3 Ligand, and Chemotherapy in HER2 Negative Breast Cancer	PHASE1	RECRUITING
Liposomal Doxorubicin and PSC 833 in Treating Patients With AIDS-Related Kaposi's Sarcoma or Other Advanced Cancers	PHASE1	COMPLETED
Choline Effects - Pre-symptomatic AD	PHASE1	COMPLETED
Duality of Lipids: the Athlete's Paradox	nan	COMPLETED
The Study Aims to Investigate the Effects of Oral Inositols on Insulin-resistance in Children With Obesity.	nan	UNKNOWN
Real-World Effectiveness of PLD in Platinum- Sensitive Recurrent Ovarian Cancer	nan	COMPLETED
Free Fatty Acid Induced Insulin Resistance	nan	COMPLETED
Effects of Probiotics on Gut Microbiota, Endocannabinoid and Immune Activation and Symptoms of Fatigue in Dancers	nan	COMPLETED
Human Requirements for the Nutrient Choline	nan	COMPLETED
Evaluating the Association Between Sphingolipid Metabolites and Post-hepatectomy Liver Failure	nan	COMPLETED
Study of the Effect of a Nutritional Supplement on Microbiota, Metabolic Control, Inflammatory Profile, and Quality of Life in Patients With Polycystic Ovary Syndrome.	nan	RECRUITING
Investigation of Secreted Phosphoproteins and PiP3 (Phosphoinositolphospat 3) in Sputum	nan	COMPLETED
Benefits of Eggs in Combination With a Plant-based Diet	nan	COMPLETED
Choline to Improve Malnutrition and Enhance Cognition	nan	RECRUITING
Composition & Function of Sarcoplasmic Reticulum in Persons With the Metabolic Syndrome	nan	COMPLETED
Effect of Omega-3 Fatty Acids Supplementation on Hypertriglyceridemia in Pediatric Patients With Obesity.	nan	COMPLETED
Lipidomic and Multi-Omics Profiling of Fatty Liver Disease in People With and Without HIV	nan	NOT_YET_RECRUITING
Whole Body Bone Scan vs 18F-Choline PET/CT in Prostate Cancer	nan	COMPLETED
Oncometabolome and MALDI-MSI in Upper GI Carcinomas - Chemosensitivity in Esophageal Carcinoma	nan	ACTIVE_NOT_RECRUITING
Precision Medicine for Sng/Pain Control	nan	COMPLETED
Myoinositol Treatment and Asprosin Levels in PCOS	nan	COMPLETED
Choline PET/CT vs. MeAIB PET/CT in Prostate Cancer	nan	WITHDRAWN
Partial PTEN Deletion in Breast Cancer	nan	UNKNOWN
Phospholipid-rich Dairy Extract for Cognitive Function	nan	RECRUITING

Related proteins — ESM-2 sequence neighbours (a CDIPT binder may also engage these)

Protein	Name	Similarity
P70500	—	1.000	P70500 →
Q8VDP6	—	1.000	Q8VDP6 →
Q8SX37	—	0.994	Q8SX37 →
Q10153	—	0.991	Q10153 →
P06197	—	0.988	P06197 →
Q59RA2	—	0.987	Q59RA2 →
Q8GUK6	—	0.981	Q8GUK6 →
Q8LBA6	—	0.979	Q8LBA6 →
O82568	—	0.971	O82568 →
Q9HXE9	—	0.970	Q9HXE9 →
O13901	—	0.970	O13901 →
P70245	—	0.967	P70245 →
P22140	—	0.967	P22140 →
O82567	—	0.966	O82567 →
P17898	—	0.966	P17898 →
Q9EQY6	—	0.966	Q9EQY6 →
Q7ZW02	—	0.966	Q7ZW02 →
Q8C2R7	—	0.965	Q8C2R7 →
O01916	—	0.965	O01916 →
P53439	—	0.965	P53439 →
Q9Y123	—	0.965	Q9Y123 →
Q0VCC1	—	0.965	Q0VCC1 →
Q2U6A4	—	0.965	Q2U6A4 →
J7FIJ6	—	0.965	J7FIJ6 →
Q9LJK3	—	0.964	Q9LJK3 →
O04928	—	0.964	O04928 →
A9CIM3	—	0.963	A9CIM3 →
O80505	—	0.963	O80505 →
Q6BZW3	—	0.963	Q6BZW3 →
Q8N2M4	—	0.963	Q8N2M4 →